ReviewEvidence: Methodology

Related impurities in peptide medicines

D'Hondt M., Bracke N., Taevernier L., Gevaert B., Verbeke F., Wynendaele E., De Spiegeleer B.

Systematic classification of impurities in synthetic peptides by origin: synthesis, degradation of the peptide, and interaction with excipients.

Key points

  • Synthesis impurities arise mainly from incomplete couplings (deletions), insertions and racemisation.
  • Degradation products form via succinimide and diketopiperazine formation and oxidation, among other routes.
  • Controlling these impurities matters not only for medicines but also for research, since by-products can influence the results of biological assays.

Assessment

Foundational work on why a purity figure alone is not enough. Our batch reports therefore list minor peaks individually. More in the article Typical impurities.

v2
Versionen